Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Refractory Benign Esophageal Stricture by Endoscopic Injection of Adipose-derived Stem Cells and Stromal Vascular Fraction

NCT07913646 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07913646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Refractory Benign Esophageal Stricture by Endoscopic Injection of Adipose-derived Stem Cells and Stromal Vascular Fraction
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
November 1, 2026
Completion date
December 31, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal stenosis acquired

Arms

As registered; 1 arm.

  • Intervention ExperimentalAdipose-derived stem cells and stromal vascular fraction

    Adipose derived stem cells and stromal vascular fraction will be injected in the benign esophageal stricture

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Resolution of dysphagia and esophageal stricture Six months

    Resolution of dysphagia defined as Mellow Pinkas score = 0 or an improvement of ≥ 2 points and esophageal luminal diameter ≥ 13 mm

Lead sponsor's other trials

Oslo University Hospital, most recent start first.

Similar trials

Same condition (Constriction, Pathologic) and phase, most recent start first.